Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Ruxolitinib cream may help treat severe hair loss in children.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Activating β-catenin increases melanocytes and decreases Schwann cells.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Pulsed electric field treatment may help shrink untreated liver tumors.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.